Aethlon Medical, Inc.
NASDAQ Capital MarketTotal Valuation
Aethlon Medical, Inc. carries a market capitalization of 456,769.00, placing it among publicly traded companies globally. Its enterprise value stands at -2.54M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 456,769.00 |
| Enterprise Value | -2.54M |
Share Statistics
Aethlon Medical, Inc. currently has 1.57M shares outstanding.
| Shares Outstanding | 1.57M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.01 |
| P/TBV Ratio | 0.44 |
| P/FCF Ratio | -0.31 |
| P/OCF Ratio | -0.31 |
Financial Position
Aethlon Medical, Inc. maintains a current ratio of 3.85, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.85 |
| Quick Ratio | 3.47 |
| Debt / Equity | 6.89 |
| Debt / EBITDA | -0.05 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -104.46 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Aethlon Medical, Inc.'s stock has declined approximately -95.71429% over the past 52 weeks. The 50-day moving average sits at 1.56, while the 200-day moving average is 2.80.
| Beta (5Y) | N/A |
| 52-Week Price Change | -95.71429% |
| 50-Day Moving Average | 1.56 |
| 200-Day Moving Average | 2.80 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -6.97M, while operating income came in at -7.29M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -7.29M |
| Pretax Income | -7.15M |
| Net Income | -7.15M |
| EBITDA | -6.97M |
| EBIT | -7.29M |
| Earnings Per Share (EPS) | -7.30 |
Balance Sheet
Aethlon Medical, Inc. holds 5.03M in cash and equivalents against 336,718.00 in total debt, resulting in a net debt position of -5.03M. Total book value stands at -175.10M, with working capital of 4.12M providing operational flexibility.
| Cash & Cash Equivalents | 5.03M |
| Total Debt | 336,718.00 |
| Net Debt | -5.03M |
| Equity (Book Value) | -175.10M |
| Book Value Per Share | -178.72 |
| Working Capital | 4.12M |
Cash Flow
Aethlon Medical, Inc. produced -7.00M in operating cash flow over the past twelve months. After subtracting -2,051.00 in capital expenditures, free cash flow totaled -7.00M - equivalent to -7.15 per share.
| Operating Cash Flow | -7.00M |
| Capital Expenditures | -2,051.00 |
| Free Cash Flow | -7.00M |
| FCF Per Share | -7.15 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -303.95 |
| FCF Yield | -326.07 |
Stock Splits
Aethlon Medical, Inc.'s most recent stock split took place on October 20, 2025 with a 10:1 split ratio.
| Last Split Date | 10/20/2025 |
| Split Ratio | 10:1 |
Scores
Aethlon Medical, Inc. posts an Altman Z-Score of -40.84, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -40.84 |